Dementia prevention in memory clinics: recommendations from the European task force for brain health services

European task force · 2023 · Switzerland

Source and licence

Authors
Giovanni B. Frisoni, Daniele Altomare, Federica Ribaldi et al.
Title
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Journal
The Lancet Regional Health - Europe, 2023
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC9989648

Licence statement of the original publication

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Recommendations

We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.

Abstract

Observational population studies indicate that prevention of dementia and cognitive decline is being accomplished, possibly as an unintended result of better vascular prevention and healthier lifestyles. Population aging in the coming decades requires deliberate efforts to further decrease its prevalence and societal burden. Increasing evidence supports the efficacy of preventive interventions on persons with intact cognition and high dementia risk. We report recommendations for the deployment of second-generation memory clinics (Brain Health Services) whose mission is evidence-based and ethical dementia prevention in at-risk individuals. The cornerstone interventions consist of (i) assessment of genetic and potentially modifiable risk factors including brain pathology, and risk stratification, (ii) risk communication with ad-hoc protocols, (iii) risk reduction with multi-domain interventions, and (iv) cognitive enhancement with cognitive and physical training. A roadmap is proposed for concept validation and ensuing clinical deployment.

Contents of the original publication

The section headings of the original.

  • Introduction
  • Current challenges in clinical practice
  • The memory clinic of the future
  • Assessment of risk of cognitive decline
  • Risk communication
  • Interventions for personalised prevention of cognitive decline
  • Interventions for cognitive enhancement
  • Cautionary notes
  • Geographical scope and generalizability
  • Target population
  • Ethical and legal framework
  • Gaps of scientific evidence
  • The roadmap for the validation of BHS
  • Contributors
  • Role of the funding source

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint